Literature DB >> 12758045

Human rhinoviruses.

Carita Savolainen1, Soile Blomqvist, Tapani Hovi.   

Abstract

Human rhinoviruses are the most important causative agents of upper respiratory infections and are also implicated in more severe clinical entities. Although often present, very little is known about human rhinoviruses. Molecular methods have been used in the classification of this large group of viruses into two separate clades. In addition, one known serotype was found to be a member of enterovirus group D. Laboratory diagnosis of human rhinovirus infection is based on reverse transcription polymerase chain reaction methods or the more tedious virus culture but a rapid "bedside" method is unavailable. Anti-rhinoviral therapy has been under extensive study over the past few decades but symptomatic treatment of the common cold is still the only useful approach in clinical use. More data on circulating human rhinovirus strains would facilitate both detection and treatment of these common pathogens.

Entities:  

Mesh:

Year:  2003        PMID: 12758045     DOI: 10.1016/s1526-0542(03)00030-7

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  15 in total

1.  Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways.

Authors:  Yin Chen; Edward Hamati; Pak-Kei Lee; Wai-Ming Lee; Shinichiro Wachi; David Schnurr; Shigeo Yagi; Gregory Dolganov; Homer Boushey; Pedro Avila; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-06       Impact factor: 6.914

2.  Negative control of TLR3 signaling by TICAM1 down-regulation.

Authors:  Shasha Tao; Lingxiang Zhu; Pakkei Lee; Wai-ming Lee; Kenneth Knox; Jie Chen; Yuanpu Peter Di; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

3.  Modulation of airway epithelial antiviral immunity by fungal exposure.

Authors:  Lingxiang Zhu; Boram Lee; Fangkun Zhao; Xu Zhou; Vanessa Chin; Serena C Ling; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

4.  Retinoic acid-inducible gene I-inducible miR-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor.

Authors:  Ryota Ouda; Koji Onomoto; Kiyohiro Takahasi; Michael R Edwards; Hiroki Kato; Mitsutoshi Yoneyama; Takashi Fujita
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

5.  Human Airway Epithelial Cells Direct Significant Rhinovirus Replication in Monocytic Cells by Enhancing ICAM1 Expression.

Authors:  Xu Zhou; Lingxiang Zhu; Rosa Lizarraga; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

6.  Amplicon sequencing and improved detection of human rhinovirus in respiratory samples.

Authors:  Christelle Deffernez; Werner Wunderli; Yves Thomas; Sabine Yerly; Luc Perrin; Laurent Kaiser
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection.

Authors:  Bogdan Jakiela; Rebecca Brockman-Schneider; Svetlana Amineva; Wai-Ming Lee; James E Gern
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-06       Impact factor: 6.914

8.  Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway.

Authors:  Lingxiang Zhu; Pak-Kei Lee; Wai-Ming Lee; Yuhua Zhao; Dongfang Yu; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

Review 9.  Microfluidic sample preparation for respiratory virus detection: A review.

Authors:  Ryan Zenhausern; Chia-Hung Chen; Jeong-Yeol Yoon
Journal:  Biomicrofluidics       Date:  2021-02-11       Impact factor: 2.800

10.  Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses.

Authors:  Luong Thi My Ngan; Myeong Jin Jang; Min Jung Kwon; Young Joon Ahn
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.